Key result
Once-daily benazepril hydrochloride resulted in clinically important reductions in diastolic and systolic blood pressures lasting 12 to 24 hours post-dose over 28 days of treatment.
Why the study?
Does once-daily oral benazepril hydrochloride reduce blood pressure in patients with mild-to-moderate hypertension?
RCT
Double-blind
randomized
Does once-daily oral benazepril hydrochloride reduce blood pressure in patients with mild-to-moderate hypertension?
Once-daily benazepril hydrochloride provides sustained blood pressure reduction over 24 hours in patients with mild-to-moderate hypertension.
Answers are grounded in this paper and cite their sources.
Supports once-daily benazepril for 24-hour BP control in mild-to-moderate hypertension; confirms sustained ACEI efficacy in RCTs.
This study evaluated the blood pressure effects of administration of once daily oral benazepril hydrochloride, a new angiotensin-converting enzyme (ACE) inhibitor, for mild-to-moderate hypertension. After a 2 to 4 week placebo baseline period, patients with diastolic blood pressure between 95 and 114 mm Hg, were randomized to receive either placebo or benazepril hydrochloride, 5, 10, 20, or 40 mg, once daily in double-blind fashion for 28 days. Blood pressure was measured predose and at 1, 2, 3, 4, 6, 8, 12, 16, 20, and 24 hours after the dose during inpatient observation days at the end of the placebo baseline period, and on the first and last day of the double-blind treatment period; and 24 hours after the dose at weekly outpatient visits. All doses of benazepril hydrochloride resulted in clinically important reductions in diastolic and systolic blood pressures that lasted between 12 and 24 hours after both the first dose, and following the last dose after 4 weeks of treatment. The findings indicate that benazepril hydrochloride may be clinically useful as once-daily monotherapy in many patients with hypertension.
No takes yet. Share an insight, caveat, or question.
Weinberger et al. (1990) conducted an RCT in mild-to-moderate hypertension. benazepril hydrochloride vs. placebo was evaluated on diastolic and systolic blood pressures. Once-daily benazepril hydrochloride resulted in clinically important reductions in diastolic and systolic blood pressures lasting 12 to 24 hours post-dose over 28 days of treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: